Postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX to improve outcomes of patients with hepatocellular carcinoma with microvascular invasion: A prospective multicenter, phase 3, randomized, controlled clinical trial.

被引：0
|
作者：
Li, Shaohua
Mei, Jie
Cheng, Yuan
Li, Qiang
Wang, Qiaoxuan
Fang, Chongkai
Lei, Qiucheng
Huang, Huakun
Cao, Mingrong
Luo, Rui
Deng, Jingduo
Jiang, Yuchuan
Zhao, Rongce
Lu, Lianghe
Zou, Jingwen
Zheng, Lie
Wei, Wei
Chen, Huanwei
Zhong, Chong
Guo, Rongping
机构：
[1] Sun Yat sen Univ Canc Ctr, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary 2, Guangzhou, Peoples R China
[3] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ Canc Ctr, Dept Radiat Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab oratory Oncol South China, Guangzhou, Peoples R China
[5] Guangzhou Univ Chinese Med, Dept Hepatobiliary Surg, Affiliated Hosp1, Guangzhou, Peoples R China
[6] Southern Med Univ, Dept Hepatobiliary Surg 2, Zhujiang Hosp, Guangzhou, Peoples R China
[7] Jinan Univ, Affiliated Hosp 1, Dept Gen Surg, Guangzhou, Peoples R China
[8] Sun Yat sen Univ Canc Ctr, Dept Imaging, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
[9] First Peoples Hosp Foshan, Foshan, Peoples R China
[10] Guangzhou Uni vers Chinese, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4013
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.
    Kuang, Ming
    Peng, Zhenwei
    Fan, Wenzhe
    Liu, Zelong
    Xiao, Han
    Tu, Jianfei
    Tang, Rong
    Huang, Zhen
    Cheng, Yu
    Li, Fuliang
    Lu, Mingjian
    Li, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 493 - 493
  • [32] Adjuvant radiotherapy after curative resection of hepatocellular carcinoma with narrow margin (≤1 cm): A phase 2, multicenter, randomized controlled trial.
    Ming, Kuang
    Peng, Zhenwei
    Chen, Zebin
    Shen, Shunli
    Li, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 722 - 722
  • [33] Tislelizumab plus hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT): A prospective, signal-arm, phase II clinical study
    Zhang, H.
    Fu, Y.
    Lu, W.
    Wang, P.
    Zhou, H.
    Zhai, J.
    Shi, C.
    Xiong, W.
    ANNALS OF ONCOLOGY, 2024, 35 : S79 - S80
  • [34] Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study).
    Zhang, Wei
    Gao, Wei
    Liu, Chen
    Li, Guangtao
    Zhang, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study)
    Zhang, W.
    Gao, W.
    Liu, C.
    Li, G.
    Zhang, Q.
    Zhou, H.
    Fang, F.
    Li, H.
    Cui, Y.
    Wu, Q.
    Zhu, X.
    Li, Q.
    Zhang, N.
    Song, T.
    Lu, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S613 - S613
  • [36] Phase II trial of hepatic arterial infusion chemotherapy using cisplatin and 5-fluorouracil in patients with advanced hepatocellular carcinoma
    Tanaka, M
    Ando, E
    Yutani, S
    Fukumori, K
    Kuromatsu, R
    Shimauchi, Y
    Nagamatsu, H
    Matsugaki, S
    Itano, S
    Ono, N
    Sakisaka, S
    Sata, M
    PROGRESS IN HEPATOCELLULAR CARCINOMA TREATMENT, 2000, : 49 - 55
  • [37] The influence of liver function on the outcomes of phase II trial of sorafenib vs. hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Kobayashi, S.
    Kondo, M.
    Morimoto, M.
    Hidaka, H.
    Nakazawa, T.
    Aikata, H.
    Hatanaka, T.
    Takizawa, D.
    Matsunaga, K.
    Okuse, C.
    Suzuki, M.
    Taguri, M.
    Ishibashi, T.
    Numata, K.
    Maeda, S.
    Tanaka, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S219 - S219
  • [38] A prospective phase II trial to evaluate the efficacy and toxicity of hepatic arterial infusion of ifosfamide in patients with inoperable localized hepatocellular carcinoma
    Malik, IA
    Khan, WA
    Haq, S
    Sabih, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (03): : 289 - 292
  • [39] Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion
    Jing Jian Sun
    Kang Wang
    Cun Zhen Zhang
    Wei Xing Guo
    Jie Shi
    Wen Ming Cong
    Meng Chao Wu
    Wan Yee Lau
    Shu Qun Cheng
    Annals of Surgical Oncology, 2016, 23 : 1344 - 1351
  • [40] Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion
    Sun, Jing Jian
    Wang, Kang
    Zhang, Cun Zhen
    Guo, Wei Xing
    Shi, Jie
    Cong, Wen Ming
    Wu, Meng Chao
    Lau, Wan Yee
    Cheng, Shu Qun
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1344 - 1351
12345